Zoledronic acid in breast cancer: latest findings and interpretations
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Zoledronic acid in breast cancer: latest findings and interpretations
Authors
Keywords
-
Journal
Therapeutic Advances in Medical Oncology
Volume 3, Issue 6, Pages 293-301
Publisher
SAGE Publications
Online
2011-09-06
DOI
10.1177/1758834011420599
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zoledronic acid as adjuvant therapy for women with early stage breast cancer and disseminated tumor cells in bone marrow
- (2017) A. Y. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- High Phosphoantigen Levels in Bisphosphonate-Treated Human Breast Tumors Promote V 9V 2 T-Cell Chemotaxis and Cytotoxicity In Vivo
- (2011) I. Benzaid et al. CANCER RESEARCH
- Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networks
- (2011) Suling Liu et al. CANCER RESEARCH
- The backbone of progress – preclinical studies and innovations with zoledronic acid
- (2011) Jonathan R. Green et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial
- (2011) Michael Gnant et al. LANCET ONCOLOGY
- Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
- (2010) H. Eidtmann et al. ANNALS OF ONCOLOGY
- Bone turnover across the menopause transition
- (2010) Kristy M. Nicks et al. Annals of the New York Academy of Sciences
- Nitrogen-containing bisphosphonates can inhibit angiogenesis in vivo without the involvement of farnesyl pyrophosphate synthase
- (2010) Verena Stresing et al. BONE
- Combined effects of the bisphosphonate, zoledronic acid and the aromatase inhibitor letrozole on breast cancer cells in vitro: evidence of synergistic interaction
- (2010) H L Neville-Webbe et al. BRITISH JOURNAL OF CANCER
- The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer
- (2010) R E Coleman et al. BRITISH JOURNAL OF CANCER
- Effect of zoledronic acid on disseminated tumour cells in women with locally advanced breast cancer: an open label, randomised, phase 2 trial
- (2010) Rebecca Aft et al. LANCET ONCOLOGY
- Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
- (2009) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Zoledronic Acid Effectively Prevents Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST Study 36-Month Follow-up Results
- (2009) Adam M. Brufsky et al. Clinical Breast Cancer
- Bisphosphonates in the Prevention of Disease Recurrence: Current Results and Ongoing Trials
- (2009) M. Gnant CURRENT CANCER DRUG TARGETS
- Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
- (2009) R.E. Coleman EUROPEAN JOURNAL OF CANCER
- Sustained inhibition of tumor growth and prolonged survival following sequential administration of doxorubicin and zoledronic acid in a breast cancer model
- (2009) Penelope D. Ottewell et al. INTERNATIONAL JOURNAL OF CANCER
- Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women
- (2009) Ana María Pino et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Endocrine Therapy plus Zoledronic Acid in Premenopausal Breast Cancer
- (2009) Michael Gnant et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo effects of zoledronic acid on peripheral γδ T lymphocytes in early breast cancer patients
- (2008) Daniele Santini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exploring the anti-tumour activity of bisphosphonates in early breast cancer
- (2008) M.C. Winter et al. CANCER TREATMENT REVIEWS
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
- (2008) Peyman Hadji CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Estradiol Rates of Change in Relation to the Final Menstrual Period in a Population-Based Cohort of Women
- (2008) MaryFran R. Sowers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Letrozole Suppresses Plasma Estradiol and Estrone Sulphate More Completely Than Anastrozole in Postmenopausal Women With Breast Cancer
- (2008) J. Michael Dixon et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor Effects of Doxorubicin Followed by Zoledronic Acid in a Mouse Model of Breast Cancer
- (2008) P. D. Ottewell et al. JNCI-Journal of the National Cancer Institute
- Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy
- (2008) Michael Gnant et al. LANCET ONCOLOGY
- The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells and unwitting host to molecular parasites
- (2008) Y Shiozawa et al. LEUKEMIA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started